WHAT YOU NEED TO KNOW Today, Roll Call published an op-ed by Matthew Lane, executive director of the Coalition Against Patent Abuse praising the ongoing bipartisan efforts to rein in Big Pharma’s abuse of the American patent system. “Finding common ground isn’t easy in today’s divided Washington. We are even seeing it in the broader drug pricing debate […]

Continue Reading

IN CASE YOU MISSED IT: This morning, The Washington Post published a must-read analysis highlighting how AbbVie’s use of tactics like patent thickets have allowed them to continue raising the price of their drug AbbVie while also preventing more affordable generic alternatives from coming to market. Today’s analysis follows recent reporting from Axios that AbbVie has begun 2020 by raising the price […]

Continue Reading

IN CASE YOU MISSED IT: Axios reports that as of Friday, major pharmaceutical companies raised prices on over 440 drugs with an average price hike of 5 percent. Additional price increases are expected thought January. Through their use of manipulative tactics like evergreening and patent thicketing, Big Pharma has been able to extend their drug monopolies and prevent competitive drug […]

Continue Reading